Chronic hepatitis B virus (HBV) infection is a common cause of liver disease globally, with a
disproportionately high burden in South-East Asia. Vaccines and nucleoside or nucleotide …

In order to validate the antiviral effect against hepatitis B virus (HBV) of Taraxacum
mongolicum (T. mongolicum), the protective effect on hepatocytes, and antiviral properties …

AIM: To explore the anti-hepatitis B virus (HBV) effects of Boehmeria nivea (B. nivea) root
extract (BNE) by using the HepG2 2.2. 15 cell model system. METHODS: Hepatitis B surface …

The matrine-type alkaloid, oxymatrine inhibits hepatitis B virus (HBV) replication but very
little is known about these effects in other matrine-type alkaloids, including sophoridine and …

Anti-hepatitis B virus (HBV) drugs are currently limited to nucleos (t) ide analogs (NAs) and
interferons. A challenge of drug development is the identification of small molecules that …

Background Long-term treatment of chronic hepatitis B (CHB) with nucleos (t) ide analogs
results in the emergence of drug-resistant hepatitis B virus (HBV) harboring mutations in the …

Hepatitis B Virus is the most common cause of chronic liver disease worldwide. Currently
approved agents of chronic HBV infection treatment include interferon and nucleoside …

Boehmeria nivea extract (BNE) is widely used in southern Taiwan as a folk medicine for
hepato‐protection and hepatitis treatment. In previous studies, we demonstrated that BNE …

Hepatitis C virus (HCV) infection is a worldwide public health burden and it is estimated that
185 million people are or have previously been infected worldwide. There is no effective …

Current treatment options against hepatitis B and D virus (HBV/HDV) infections have only
limited curative effects. Identification of Na+/taurocholate co-transporting polypeptide …